Type 1 Endoleak : Fenestrated Custom Made Endograft (FEVAR) Versus Open Surgery Explantation (OSR) : What's the Best
- Conditions
- Aorta Aneurysm
- Interventions
- Device: ExplantationDevice: FEVAR
- Registration Number
- NCT06187051
- Lead Sponsor
- University Paul Sabatier of Toulouse
- Brief Summary
Proximal type 1A endoleak is a worrying complication after endovascular repair of an abdominal aortic aneurysm (EVAR). The ideal solution is not obvious between relining by FEVAR and endograft explantation.
A retrospective french multicentric study was performed between 2010 and 2023 to compare the outcomes and the efficiency of both technics and propose a decision algorithm for the management of type 1A endoleak after EVAR.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
- Type 1A endoleak after EVAR
- no
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patient presenting a type 1A endoleak after EVAR treated by explantation of the EVAR Explantation - Patient presenting a type 1A endoleak after EVAR treated by relining with FEVAR FEVAR -
- Primary Outcome Measures
Name Time Method Redo surgery after type 1A endoleak surgery 30 day, 6 months, 12 months, 24 months Reintervention after FEVAR or explantation surgery
Major adverse cardiovascular event (MACE) post operative day 30 post operative Patient presenting after surgery a composite score (MACE) including
* nonfatal stroke,
* nonfatal myocardial infarction
* cardiovascular deathPost operative mortality day 30 post operative Patient death after the treatment of type 1A endoleak
- Secondary Outcome Measures
Name Time Method Efficiency of the treatment 30 day, 6 months, 12 months, 24 months No reintervention after open surgery or Thrombosis of the aneurysmal sac after FEVAR
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.